A major international clinical trial has found that finerenone can significantly slow the loss of kidney function in people with chronic kidney disease (CKD) who do not have diabetes. The findings suggest the drug could become an important new…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply